Artificial Intelligence is becoming ubiquitous in products and services that we use daily. Although the domain of AI has seen substantial improvements over recent years, its effectiveness is limited by the capabilities of current computing technology. Recently, there have been several architectural innovations for AI using emerging nanotechnology. These architectures implement mathematical computations of AI with circuits that utilize physical behavior of nanodevices purpose-built for such computations. This approach leads to a much greater efficiency vs.
The machinery of life operates on the complex interactions between genes and proteins. Attempts to capture these interactions have culminated into the study of Genetic Networks. Genetic defects lead to erroneous interactions, which in turn lead to diseases. For personalized treatment of these diseases, a careful analysis of Genetic Networks and a patient’s genetic data is required. In this work, we co-design a novel probabilistic AI model along with a reconfigurable architecture to enable personalized treatment for cancer patients.
Hardware implementations of artificial neural networks (ANNs) have become feasible due to the advent of persistent 2-terminal devices such as memristor, phase change memory, MTJs, etc. Hybrid memristor crossbar/CMOS systems have been studied extensively and demonstrated experimentally. In these circuits, memristors located at each cross point in a crossbar are, however, stacked on top of CMOS circuits using back end of line processing (BOEL), limiting scaling.